Cencora (LTS:0HF3) ROE % Adjusted to Book Value : 3.80% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Cencora ROE % Adjusted to Book Value?

Cencora's ROE % for the quarter that ended in Mar. 2024 was 168.74%. Cencora's PB Ratio for the quarter that ended in Mar. 2024 was 44.38. Cencora's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was 3.80%.

Cencora ROE % Adjusted to Book Value Historical Data

The historical data trend for Cencora's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cencora ROE % Adjusted to Book Value Chart

Cencora Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

5.00

Negative Equity

16.20

Cencora Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															29.34	6.98	3.35	7.52	3.80

Competitive Comparison of Cencora's ROE % Adjusted to Book Value

For the Medical Distribution subindustry, Cencora's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cencora's ROE % Adjusted to Book Value Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cencora's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Cencora's ROE % Adjusted to Book Value falls into.

Cencora ROE % Adjusted to Book Value Calculation

Cencora's ROE % Adjusted to Book Value for the fiscal year that ended in Sep. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	1,124.39%	/	69.39
	=	16.20%

Cencora's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	168.74%	/	44.38
	=	3.80%

Cencora ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Cencora's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Cencora (LTS:0HF3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cencora Inc (LTS:0HF3) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

COR:USA ABG:Germany C1CO34:Brazil ABC:Austria

Address

1 West First Avenue, Conshohocken, PA, USA, 19428-1800

Website

https://www.cencora.com

Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the U.S. pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Cencora (LTS:0HF3) Headlines

No Headlines